Motor dysfunction within the schizophrenia-spectrum: A dimensional step towards an underappreciated domain

Schizophrenia Research

Volumn 169, Issue 1-3, 2015, Pages 217-233

  Hirjak, Dusan ^a   Thomann, Philipp A ^a   Kubera, Katharina M ^a   Wolf, Nadine D ^b   Sambataro, Fabio ^c   Wolf, Robert C ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Abnormal involuntary movements; Catatonic symptoms; Neuroimaging; Neurological soft signs; Schizophrenia

Indexed keywords

ABNORMAL INVOLUNTARY MOVEMENT SCALE; BRAIN DYSFUNCTION; BRAIN FUNCTION; DYSKINESIA; GENUINE MOTOR ABNORMALITY; HEIDELBERG NEUROLOGICAL SOFT SIGN SCALE; HUMAN; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROLOGICAL EVALUATION SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SCORING SYSTEM; SIMPSON ANGUS SCALE; STRUCTURAL MAGNETIC RESONANCE IMAGING; SYSTEMATIC REVIEW; COMPLICATION; MOVEMENT DISORDERS; PSYCHOLOGY;

HUMANS; MOVEMENT DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84953839168     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.10.022     Document Type: Review

References (181)

1. Agid O., Mamo D., Ginovart N., Vitcu I., Wilson A.A., Zipursky R.B., Kapur S. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia. Neuropsychopharmacology 2007, 32(6):1209-1215.
2. Altshuler L.L., Cummings J.L., Bartzokis G., Hill M.A., May P.R. Lateral asymmetries of tardive dyskinesia in schizophrenia. Biol. Psychiatry 1988, 24(1):83-86.
3. Andreasen N.C., Paradiso S., O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophr. Bull. 1998, 24(2):203-218.
4. Baare W.F., van Oel C.J., Hulshoff Pol H.E., Schnack H.G., Durston S., Sitskoorn M.M., Kahn R.S. Volumes of brain structures in twins discordant for schizophrenia. Arch. Gen. Psychiatry 2001, 58(1):33-40.
5. Bachmann S., Bottmer C., Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am. J. Psychiatry 2005, 162(12):2337-2343.
6. Bachmann S., Degen C., Geider F.J., Schroder J. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis. Front. Psychiatry 2014, 5:185.
7. Bai Y.M., Chou K.H., Lin C.P., Chen I.Y., Li C.T., Yang K.C., Chou Y.H., Su T.P. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr. Res. 2009, 109(1-3):167-181.
8. Bartzokis G., Garber H.J., Marder S.R., Olendorf W.H. MRI in tardive dyskinesia: shortened left caudate T2. Biol. Psychiatry 1990, 28(12):1027-1036.
9. Baudendistel K., Schad L.R., Wenz F., Essig M., Schröder J., Jahn T., Knopp M.V., Lorenz W.J. Monitoring of task performance during functional magnetic resonance imaging of sensorimotor cortex at 1.5 T Magn. Reson. Imaging 1996, 14(1):51-58.
10. Behere R.V. Dorsolateral prefrontal lobe volume and neurological soft signs as predictors of clinical social and functional outcome in schizophrenia: A longitudinal study.Indian J. Psychiatry 2013, 55(2):111-116. 10.4103/0019-5545.111445.
11. Bermanzohn P.C., Siris S.G. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Compr. Psychiatry 1992, 33(4):221-232.
12. Bernard J.A., Dean D.J., Kent J.S., Orr J.M., Pelletier-Baldelli A., Lunsford-Avery J.R., Gupta T., Mittal V.A. Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity. Hum. Brain Mapp. 2014, 35(8):4064-4078.
13. Bernard J.A., Mittal V.A. Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front. Psychiatry 2014, 5:160.
14. Bernard J.A., Mittal V.A. Updating the research domain criteria: the utility of a motor dimension. Psychol. Med. 2015, 1-5.
15. Bersani G., Paolemili M., Quartini A., Clemente R., Gherardelli S., Iannitelli A., Di Biasi C., Gualdi G., Pancheri P. Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients. Neurosci. Lett. 2007, 413(1):82-87. Epub 2006 Dec 14.
16. Bersani G., Quartini A., Paolemili M., Clemente R., Iannitelli A., Di Biasi C., Gualdi G. Neurological soft signs and corpus callosum morphology in schizophrenia. Neurosci. Lett. 2011, 499(3):170-174.
17. Besson J.A., Corrigan F.M., Cherryman G.R., Smith F.W. Nuclear magnetic resonance brain imaging in chronic schizophrenia. Br. J. Psychiatry 1987, 150:161-163.
18. Billstedt E., Gillberg I.C., Gillberg C. Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J. Autism Dev. Disord. 2005, 35(3):351-360.
19. Blanchet P.J., Normandeau L., Rompre P.H. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study. Schizophr. Res. 2012, 137(1-3):230-233.
20. Bohlken M.M., Mandl R.C., Brouwer R.M., van den Heuvel M.P., Hedman A.M., Kahn R.S., Hulshoff Pol H.E. Heritability of structural brain network topology: a DTI study of 156 twins. Hum. Brain Mapp. 2014, 35(10):5295-5305.
21. Bombin I., Arango C., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr. Bull. 2005, 31(4):962-977.
22. Borgwardt S.J., Riecher-Rossler A., Smieskova R., McGuire P.K., Fusar-Poli P. Superior temporal gray and white matter changes in schizophrenia or antipsychotic related effects?. Schizophr. Res. 2009, 113(1):109-110.
23. Borgwardt S.J., Smieskova R., Fusar-Poli P., Bendfeldt K., Riecher-Rossler A. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?. Psychol. Med. 2009, 39(11):1781-1782.
24. Bottmer C., Bachmann S., Pantel J., Essig M., Amann M., Schad L.R., Magnotta V., Schroder J. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res. 2005, 140(3):239-250.
25. Brans R.G., van Haren N.E., van Baal G.C., Schnack H.G., Kahn R.S., Hulshoff Pol H.E. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch. Gen. Psychiatry 2008, 65(11):1259-1268.
26. Brans R.G., van Haren N.E., van Baal G.C., Staal W.G., Schnack H.G., Kahn R.S., Hulshoff Pol H.E. Longitudinal MRI study in schizophrenia patients and their healthy siblings. Br. J. Psychiatry 2008, 193(5):422-423.
27. Buchanan R.W., Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989, 27(3):335-350.
28. Buckley P., O'Callaghan E., Mulvany F., Larkin C., Stack J.P., Redmond O., Ennis J.T., Thompson P., Waddington J.L. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia. Psychiatry Res. 1995, 61(2):95-102.
29. Cazorla M., Kang U.J., Kellendonk C. Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Mov. Disord. 2015, 30(7):895-903.
30. Chan R.C., Rao H., Chen E.E., Ye B., Zhang C. The neural basis of motor sequencing: an fMRI study of healthy subjects. Neurosci. Lett. 2006, 398(3):189-194.
31. Chan R.C., Gottesman I.I. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?. Neurosci. Biobehav. Rev. 2008, 32(5):957-971.
32. Chan R.C., Xu T., Heinrichs R.W., Yu Y., Gong Q.Y. Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2010, 34(6):889-896.
33. Chan R.C., Xu T., Heinrichs R.W., Yu Y., Wang Y. Neurological soft signs in schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36(6):1089-1104.
34. Chan R.C.K., Gottesman I.I. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?. SO - Neurosci. Biobehav. Rev. 2008, 32.
35. Chen E.Y., Shapleske J., Luque R., McKenna P.J., Hodges J.R., Calloway S.P., Hymas N.F., Dening T.R., Berrios G.E. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995, 56(2):183-204.
36. Chrobak A.A., Siwek G.P., Siuda-Krzywicka K., Arciszewska A., Starowicz-Filip A., Siwek M., Dudek D. Neurological and cerebellar soft signs do not discriminate schizophrenia from bipolar disorder patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2016, 64:96-101.
37. Compton M.T., Fantes F., Wan C.R., Johnson S., Walker E.F. Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs. Psychiatry Res. 2015, 226(1):192-197.
38. Convit A., Jaeger J., Lin S.P., Meisner M., Volavka J. Predicting assaultiveness in psychiatric inpatients: a pilot study. Hosp. Community Psychiatry 1988, 39(4):429-434.
39. Critchley M. The Parietal Lobes 1953, Hafner, New York.
40. Cummings J., Wirshing W. Movement disorders in schizophrenia. Movement Disorders in Neurology and Neuropsychiatry 1992, 407-413. Blackwell Scientific Publications, Cambridge MA. A. Joseph, R. Young (Eds.).
41. Cuthbert B.N. Research domain criteria: toward future psychiatric nosology. Asian J. Psychiatry 2014, 7(1):4-5.
42. Cuthbert B.N., Kozak M.J. Constructing constructs for psychopathology: the NIMH research domain criteria. J. Abnorm. Psychol. 2013, 122(3):928-937.
43. Dazzan P., Morgan K.D., Orr K.G., Hutchinson G., Chitnis X., Suckling J., Fearon P., Salvo J., McGuire P.K., Mallett R.M., Jones P.B., Leff J., Murray R.M. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004, 127(Pt 1):143-153.
44. Dean D.J., Kent J.S., Bernard J.A., Orr J.M., Gupta T., Pelletier-Baldelli A., Carol E.E., Mittal V.A. Increased postural sway predicts negative symptom progression in youth at ultrahigh risk for psychosis. Schizophr. Res. 2015, 162(1-3):86-89.
45. Dhossche D.M. Autism as early expression of catatonia. Med. Sci. Monit. 2004, 10(3):RA31-RA39.
46. Dhossche D.M., Stanfill S. Could ECT be effective in autism?. Med. Hypotheses 2004, 63(3):371-376.
47. Elkashef A.M., Buchanan R.W., Gellad F., Munson R.C., Breier A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Am. J. Psychiatry 1994, 151(5):752-755.
48. Fenton W.S., Blyler C.R., Wyatt R.J., McGlashan T.H. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients. Br. J. Psychiatry 1997, 171:265-268.
49. Fink M. Clinical practice to change with divorce of catatonia and schizophrenia. J. Clin. Psychopharmacol. 2013, 33(3):287-288.
50. Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr. Scand. Suppl. 2013, (441):1-47.
51. Fink M., Shorter E., Taylor M.A. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr. Bull. 2010, 36(2):314-320.
52. Fink M., Taylor M.A. The catatonia syndrome: forgotten but not gone. Arch. Gen. Psychiatry 2009, 66(11):1173-1177.
53. Friedman J.H. Historical perspective on movement disorders. J. Clin. Psychiatry 2004, 65(Suppl. 9):3-8.
54. Fusar-Poli P., Deste G., Smieskova R., Barlati S., Yung A.R., Howes O., Stieglitz R.D., Vita A., McGuire P., Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry 2012, 69(6):562-571.
55. Galynker I.I., Weiss J., Ongseng F., Finestone H. ECT treatment and cerebral perfusion in Catatonia. J. Nucl. Med. 1997, 38(2):251-254.
56. Gay O., Plaze M., Oppenheim C., Mouchet-Mages S., Gaillard R., Olie J.P., Krebs M.O., Cachia A. Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr. Bull. 2012.
57. Ghaziuddin N., Gih D., Barbosa V., Maixner D.F., Ghaziuddin M. Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents. J. ECT 2010, 26(4):274-277.
58. Granholm E., Bartzokis G., Asarnow R.F., Marder S.R. Preliminary associations between motor procedural learning, basal ganglia T2 relaxation times, and tardive dyskinesia in schizophrenia. Psychiatry Res. 1993, 50(1):33-44.
59. Graybiel A.M. The basal ganglia and the initiation of movement. Rev. Neurol. 1990, 146(10):570-574.
60. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990, 13(7):244-254.
61. Greenberg K., D'Ambrosio M., Liebman K.M., Veznedaroglu E. Wax on, wax off: a rare case of catatonia. Am. J. Emerg. Med. 2014, 32(10):e1303-e1304. (1303).
62. Halliday J., Farrington S., Macdonald S., MacEwan T., Sharkey V., McCreadie R. Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review. Br. J. Psychiatry 2002, 181:422-427.
63. Heckers S. Bleuler and the neurobiology of schizophrenia. Schizophr. Bull. 2011, 37(6):1131-1135.
64. Heinz R., Rayasam K., Krishnan K.R., Wingfield M., Irigaray P., Ellinwood E.H. MRI scans in patients with tardive dyskinesia. Biol. Psychiatry 1988, 24(7):852-857.
65. Heuser M., Thomann P.A., Essig M., Bachmann S., Schroder J. Neurological signs and morphological cerebral changes in schizophrenia: an analysis of NSS subscales in patients with first episode psychosis. Psychiatry Res. 2011, 192(2):69-76.
66. Hirjak D., Kubera K.M., Wolf R.C., Thomann A.K., Hell S.K., Seidl U., Thomann P.A. Local brain gyrification as a marker of neurological soft signs in schizophrenia. Behav. Brain Res. 2015.
67. Hirjak D., Thomann P.A., Kubera K.M., Stieltjes B., Wolf R.C. Cerebellar contributions to neurological soft signs in healthy young adults. Eur. Arch. Psychiatry Clin. Neurosci. 2015.
68. Hirjak D., Wolf R.C., Kubera K.M., Stieltjes B., Meier-Hein K., Thomann P.A. Neurological soft signs in recent-onset schizophrenia: focus on the cerebellum. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2015.
69. Hirjak D., Wolf R.C., Kubera K.M., Stieltjes B., Thomann P.A. Multiparametric mapping of neurological soft signs in healthy adults. Brain Struct. Funct. 2014.
70. Hirjak D., Wolf R.C., Stieltjes B., Hauser T., Seidl U., Schroder J., Thomann P.A. Cortical signature of neurological soft signs in recent onset schizophrenia. Brain Topogr. 2013.
71. Hirjak D., Wolf R.C., Stieltjes B., Hauser T., Seidl U., Schroder J., Thomann P.A. Cortical signature of neurological soft signs in recent onset schizophrenia. Brain Topogr. 2014, 27(2):296-306.
72. Hirjak D., Wolf R.C., Stieltjes B., Hauser T., Seidl U., Thiemann U., Schroder J., Thomann P.A. Neurological soft signs and brainstem morphology in first-episode schizophrenia. Neuropsychobiology 2013, 68(2):91-99.
73. Hirjak D., Wolf R.C., Stieltjes B., Seidl U., Schroder J., Thomann P.A. Neurological soft signs and subcortical brain morphology in recent onset schizophrenia. J. Psychiatr. Res. 2012, 46(4):533-539.
74. Hirjak D., Wolf R.C., Wilder-Smith E.P., Kubera K.M., Thomann P.A. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain Topogr. 2014.
75. Ho S.S., Berkovic S.F., Newton M.R., Austin M.C., McKay W.J., Bladin P.F. Parietal lobe epilepsy: clinical features and seizure localization by ictal SPECT. Neurology 1994, 44(12):2277-2284.
76. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., Brans R.G., van Haren N.E., Baare W.F., van Oel C.J., Collins D.L., Evans A.C., Kahn R.S. Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. NeuroImage 2006, 31(2):482-488.
77. Huttlova J., Kikinis Z., Kerkovsky M., Bouix S., Vu M.A., Makris N., Shenton M., Kasparek T. Abnormalities in myelination of the superior cerebellar peduncle in patients with schizophrenia and deficits in movement sequencing. Cerebellum 2014, 13(4):415-424.
78. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167(7):748-751.
79. Iseki K., Ikeda A., Kihara T., Kawamoto Y., Mezaki T., Hanakawa T., Hashikawa K., Fukuyama H., Shibasaki H. Impairment of the cortical GABAergic inhibitory system in catatonic stupor: a case report with neuroimaging. Epileptic Disord. 2009, 11(2):126-131.
80. Jahn T., Hubmann W., Karr M., Mohr F., Schlenker R., Heidenreich T., Cohen R., Schroder J. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Res. 2006, 142(2-3):191-199.
81. Janssen J., Diaz-Caneja A., Reig S., Bombin I., Mayoral M., Parellada M., Graell M., Moreno D., Zabala A., Vazquez V.G., Desco M., Arango C. Brain morphology and neurological soft signs in adolescents with first-episode psychosis. Br. J. Psychiatry 2009, 195(3):227-233.
82. Kahlbaum K. The clinico-diagnostic perspective in psychopathology. 1878. Hist. Psychiatry 2007, 18(70 Pt 2):233-245.
83. Kahlbaum K.L. Die Katatonie oder das Spannungsirresein 1874, Verlag August Hirschwald, Berlin.
84. Kasparek T., Prikryl R., Schwarz D., Tronerova S., Ceskova E., Mikl M., Vanicek J. Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia. World J. Biol. Psychiatry 2009, 10(4 Pt 3):752-762.
85. Khot V., Wyatt R.J. Not all that moves is tardive dyskinesia. Am. J. Psychiatry 1991, 148(5):661-666.
86. Kodama S., Fukuzako H., Fukuzako T., Kiura T., Nozoe S., Hashiguchi T., Yamada K., Takenouchi K., Takigawa M., Nakabeppu Y., Nakajo M. Aberrant brain activation following motor skill learning in schizophrenic patients as shown by functional magnetic resonance imaging. Psychol. Med. 2001, 31(6):1079-1088.
87. Kong L., Bachmann S., Thomann P.A., Essig M., Schröder J. Neurological soft signs and gray matter changes: a longitudinal analysis in first-episode schizophrenia, Schizophr. Res. 2012, 134(1):27-32. 10.1016/j.schres.2011.09.015.
88. Kong L., Herold C.J., Lasser M.M., Schmid L.A., Hirjak D., Thomann P.A., Essig M., Schroder J. Association of cortical thickness and neurological soft signs in patients with chronic schizophrenia and healthy controls. Neuropsychobiology 2015, 71(4):225-233.
89. Krebs M.O., Gut-Fayand A., Bourdel M., Dischamp J., Olie J. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr. Res. 2000, 45(3):245-260.
90. Kuhn S., Romanowski A., Schilling C., Banaschewski T., Barbot A., Barker G.J., Bruhl R., Buchel C., Conrod P.J., Czech K., Dalley J.W., Flor H., Garavan H., Hake I., Ittermann B., Ivanov N., Mann K., Lathrop M., Loth E., Ludemann K., Mallik C., Martinot J.L., Palafox C., Poline J.B., Reuter J., Rietschel M., Robbins T.W., Smolka M.N., Nees F., Walaszek B., Schumann G., Heinz A., Gallinat J., Consortium, I. Manual dexterity correlating with right lobule VI volume in right-handed 14-year-olds. NeuroImage 2012, 59(2):1615-1621.
91. Kuo Y.L., Tsai H.F., Lai M.C., Lin C.H., Yang Y.K. Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania. J. Clin. Neurosci. 2012, 19(6):896-898.
92. Lee E.M., Kang J.K., Oh J.S., Kim J.S., Shin Y.W., Kim C.Y. 18F-fluorodeoxyglucose positron-emission tomography findings with anti-N-methyl-d-aspartate receptor encephalitis that showed variable degrees of catatonia: three cases report. J. Epilepsy Res. 2014, 4(2):69-73.
93. Li C.T., Chou K.H., Su T.P., Huang C.C., Chen M.H., Bai Y.M., Lin C.P. Gray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study. PLoS One 2013, 8(8).
94. Lishman W.A. Organic Psychiatry 1978, Blackwell, Oxford.
95. Luchins D.J., Metz J.T., Marks R.C., Cooper M.D. Basal ganglia regional glucose metabolism asymmetry during a catatonic episode. Biol. Psychiatry 1989, 26(7):725-728.
96. Maatz A., Hoff P., Angst J. Eugen Bleuler's schizophrenia-a modern perspective. Dialogues Clin. Neurosci. 2015, 17(1):43-49.
97. Maixner D., Sagher O., Bess J., Edwards J. Catatonia following surgery for temporal lobe epilepsy successfully treated with electroconvulsive therapy. Epilepsy Behav. 2010, 19(3):528-532.
98. Mamah D., Harms M.P., Wang L., Barch D., Thompson P., Kim J., Miller M.I., Csernansky J.G. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biol. Psychiatry 2008, 64(2):111-120.
99. Mazzone L., Postorino V., Valeri G., Vicari S. Catatonia in patients with autism: prevalence and management. CNS Drugs 2014, 28(3):205-215.
100. McCreadie R.G., Thara R., Padmavati R., Srinivasan T.N., Jaipurkar S.D. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch. Gen. Psychiatry 2002, 59(4):332-336.
101. Mion C.C., Andreasen N.C., Arndt S., Swayze V.W., Cohen G.A. MRI abnormalities in tardive dyskinesia. Psychiatry Res. 1991, 40(3):157-166.
102. Mittal V.A., Daley M., Shiode M.F., Bearden C.E., O'Neill J., Cannon T.D. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr. Res. 2010, 123(1):68-70.
103. Mittal V.A., Dean D.J., Bernard J.A., Orr J.M., Pelletier-Baldelli A., Carol E.E., Gupta T., Turner J., Leopold D.R., Robustelli B.L., Millman Z.B. Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr. Bull. 2013.
104. Mittal V.A., Tessner K.D., Trottman H.D., Esterberg M., Dhrub S.H., Simeonova D.I., McMillan A.L., Murphy E., Saczawa M.E., Walker E.F. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. J. Abnorm. Psychol. 2007, 116(2):260-267.
105. Mittal V.A., Walker E.F. Movement abnormalities: a putative biomarker of risk for psychosis. Volume I: Neuropsychological Endophenotypes and Biomarkers 2009, 239-258. Springer. M.S. Ritschner (Ed.).
106. Morris S.E., Cuthbert B.N. Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin. Neurosci. 2012, 14(1):29-37.
107. Moskowitz A., Heim G. Eugen Bleuler's dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration. Schizophr. Bull. 2011, 37(3):471-479.
108. Mouchet-Mages S., Canceil O., Willard D., Krebs M.O., Cachia A., Martinot J.L., Rodrigo S., Oppenheim C., Meder J.F. Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr. Res. 2007, 91(1-3):266-269.
109. Mouchet-Mages S., Rodrigo S., Cachia A., Mouaffak F., Olie J.P., Meder J.F., Oppenheim C., Krebs M.O. Correlations of cerebello-thalamo-prefrontal structure and neurological soft signs in patients with first-episode psychosis. Acta Psychiatr. Scand. 2011, 123(6):451-458.
110. Muller J.L., Roder C.H., Schuierer G., Klein H. Motor-induced brain activation in cortical, subcortical and cerebellar regions in schizophrenic inpatients. A whole brain fMRI fingertapping study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2002, 26(3):421-426.
111. Neelam K., Garg D., Marshall M. A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry 2011, 11(1):1-8.
112. Negash A., Kebede D., Alem A., Melaku Z., Deyessa N., Shibire T., Fekadu A., Fekadu D., Jacobsson L., Kullgren G. Neurological soft signs in bipolar I disorder patients. J. Affect. Disord. 2004, 80(2-3):221-230.
113. Northoff G. Brain imaging in catatonia: current findings and a pathophysiologic model. CNS Spectr. 2000, 5(7):34-46.
114. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav. Brain Sci. 2002, 25(5):555-577. (discussion 578-604).
115. Northoff G., Braus D.F., Sartorius A., Khoram-Sefat D., Russ M., Eckert J., Herrig M., Leschinger A., Bogerts B., Henn F.A. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol. Med. 1999, 29(4):997-1002.
116. Northoff G., Kotter R., Baumgart F., Danos P., Boeker H., Kaulisch T., Schlagenhauf F., Walter H., Heinzel A., Witzel T., Bogerts B. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr. Bull. 2004, 30(2):405-427.
117. Northoff G., Pfennig A., Krug M., Danos P., Leschinger A., Schwarz A., Bogerts B. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. Schizophr. Res. 2000, 44(3):193-211.
118. Northoff G., Steinke R., Czcervenka C., Krause R., Ulrich S., Danos P., Kropf D., Otto H., Bogerts B. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J. Neurol. Neurosurg. Psychiatry 1999, 67(4):445-450.
119. Northoff G., Steinke R., Nagel D.C., Grosser O., Danos P., Genz A., Krause R., Boker H., Otto H.J., Bogerts B. Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol. Med. 2000, 30(3):583-596.
120. Owens D.G. Involuntary disorders of movement in chronic schizophrenia-the role of the illness and its treatment. Psychopharmacology Suppl. 1985, 2:79-87.
121. Pappa S., Dazzan P. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol. Med. 2009, 39(7):1065-1076.
122. Payoux P., Boulanouar K., Sarramon C., Fabre N., Descombes S., Galitsky M., Thalamas C., Brefel-Courbon C., Sabatini U., Manelfe C., Chollet F., Schmitt L., Rascol O. Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study. Mov. Disord. 2004, 19(1):83-90.
123. Peralta V., Campos M.S., De Jalon E.G., Cuesta M.J. Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov. Disord. 2010, 25(8):1068-1076.
124. Peralta V., Cuesta M.J. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr. Res. 2001, 47(2-3):107-116.
125. Peralta V., Cuesta M.J. Eugen Bleuler and the schizophrenias: 100years after. Schizophr. Bull. 2011, 37(6):1118-1120.
126. Peralta V., de Jalon E.G., Campos M.S., Basterra V., Sanchez-Torres A., Cuesta M.J. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders. Psychol. Med. 2011, 41(6):1279-1289.
127. Peralta V., de Jalon E.G., Campos M.S., Cuesta M.J. Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-spectrum disorders. J. Clin. Psychopharmacol. 2013, 33(3):438-440.
128. Peralta V., Moreno-Izco L., Sanchez-Torres A., Garcia de Jalon E., Campos M.S., Cuesta M.J. Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr. Bull. 2014, 40(1):214-224.
129. Phal P.M., Usmanov A., Nesbit G.M., Anderson J.C., Spencer D., Wang P., Helwig J.A., Roberts C., Hamilton B.E. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy. AJR. Am. J. Roentgenol. 2008, 191(3):890-895.
130. Quitkin F., Rifkin A., Klein D.F. Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch. Gen. Psychiatry 1976, 33(7):845-853.
131. Richter A., Grimm S., Northoff G. Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia. Hum. Psychopharmacol. 2010, 25(1):55-62.
132. Roberts D.R. Catatonia in the brain: a localization study. Int. J. Neuropsychiatry 1965, 1(4):395-403.
133. Rogers D. Catatonia: a contemporary approach. J. Neuropsychiatry Clin. Neurosci. 1991, 3(3):334-340.
134. Rogers D. Motor Disorder in Psychiatry. Towards a Neurological Psychiatry 1992, John Wiley & Sons, Chichester.
135. Rogowska J., Gruber S.A., Yurgelun-Todd D.A. Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation. Psychiatry Res. 2004, 130(3):227-243.
136. Rossi A., De Cataldo S., Di Michele V., Manna V., Ceccoli S., Stratta P., Casacchia M. Neurological soft signs in schizophrenia. Br. J. Psychiatry 1990, 157:735-739.
137. Rubia K., Russell T., Bullmore E.T., Soni W., Brammer M.J., Simmons A., Taylor E., Andrew C., Giampietro V., Sharma T. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr. Res. 2001, 52(1-2):47-55.
138. Sarro S., Pomarol-Clotet E., Canales-Rodriguez E.J., Salvador R., Gomar J.J., Ortiz-Gil J., Landin-Romero R., Vila-Rodriguez F., Blanch J., McKenna P.J. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br. J. Psychiatry 2012.
139. Satoh K., Narita M., Someya T., Fukuyama H., Yonekura Y. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies. Jpn. J. Psychiatry Neurol. 1993, 47(4):881-885.
140. Satoh K., Suzuki T., Narita M., Ishikura S., Shibasaki M., Kato T., Takahashi S., Fukuyama H., Ohnishi H., Morita R. Regional cerebral blood flow in catatonic schizophrenia. Psychiatry Res. 1993, 50(4):203-216.
141. Saunders A., Oldenburg I.A., Berezovskii V.K., Johnson C.A., Kingery N.D., Elliott H.L., Xie T., Gerfen C.R., Sabatini B.L. A direct GABAergic output from the basal ganglia to frontal cortex. Nature 2015, 521(7550):85-89.
142. Scheibel A.B. The thalamus and neuropsychiatric illness. J. Neuropsychiatr. Clin. Neurosci. 1997, 9(3):342-353.
143. Scherk H., Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 2006, 19(2):145-150.
144. Scheuerecker J., Ufer S., Kapernick M., Wiesmann M., Bruckmann H., Kraft E., Seifert D., Koutsouleris N., Moller H.J., Meisenzahl E.M. Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. J. Psychiatr. Res. 2009, 43(6):607-614.
145. Schonecker M. Paroxysmal dyskinesia as the effect of megaphen. Nervenarzt 1957, 28(12):550-553.
146. Schroder J., Essig M., Baudendistel K., Jahn T., Gerdsen I., Stockert A., Schad L.R., Knopp M.V. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. NeuroImage 1999, 9(1):81-87.
147. Schroder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., Sauer H. Neurological soft signs in schizophrenia. Schizophr. Res. 1991, 6(1):25-30.
148. Schroder J., Wenz F., Schad L.R., Baudendistel K., Knopp M.V. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. Br. J. Psychiatry 1995, 167(2):197-201.
149. Sienaert P., Rooseleer J., De Fruyt J. Measuring catatonia: a systematic review of rating scales. J. Affect. Disord. 2011, 135(1-3):1-9.
150. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? A systematic review. Curr. Pharm. Des. 2009, 15(22):2535-2549.
151. Smith G.N., Thornton A.E., Lang D.J., MacEwan G.W., Kopala L.C., Su W., Honer W.G. Cortical morphology and early adverse birth events in men with first-episode psychosis. Psychol. Med. 2014, 1-13.
152. Smith J.H., Smith V.D., Philbrick K.L., Kumar N. Catatonic disorder due to a general medical or psychiatric condition. J. Neuropsychiatry Clin. Neurosci. 2012, 24(2):198-207.
153. Stoodley C.J., Schmahmann J.D. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010, 46(7):831-844.
154. Stoodley C.J., Valera E.M., Schmahmann J.D. An fMRI study of intra-individual functional topography in the human cerebellum. Behav. Neurol. 2010, 23(1-2):65-79.
155. Sui J., Adali T., Yu Q., Chen J., Calhoun V.D. A review of multivariate methods for multimodal fusion of brain imaging data. J. Neurosci. Methods 2012, 204(1):68-81.
156. Sui J., Yu Q., He H., Pearlson G.D., Calhoun V.D. A selective review of multimodal fusion methods in schizophrenia. Front. Hum. Neurosci. 2012, 6:27.
157. Tamagni C., Studerus E., Gschwandtner U., Aston J., Borgwardt S., Riecher-Rossler A. Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?. Psychiatry Res. 2013, 210(2):427-431.
158. Tandon R., Heckers S., Bustillo J., Barch D.M., Gaebel W., Gur R.E., Malaspina D., Owen M.J., Schultz S., Tsuang M., van Os J., Carpenter W. Catatonia in DSM-5. Schizophr. Res. 2013, 150(1):26-30.
159. Thomann P.A., Hirjak D., Kubera K.M., Stieltjes B., Wolf R.C. Neural network activity and neurological soft signs in healthy adults. Behav. Brain Res. 2015, 278:514-519.
160. Thomann P.A., Roebel M., Dos Santos V., Bachmann S., Essig M., Schroder J. Cerebellar substructures and neurological soft signs in first-episode schizophrenia. Psychiatry Res. 2009, 173(2):83-87.
161. Thomann P.A., Wustenberg T., Santos V.D., Bachmann S., Essig M., Schroder J. Neurological soft signs and brain morphology in first-episode schizophrenia. Psychol. Med. 2009, 39(3):371-379.
162. Torrey E.F. Schizophrenia and the inferior parietal lobule. Schizophr. Res. 2007, 97(1-3):215-225.
163. Turner T. Rich and mad in Victorian England. Psychol. Med. 1989, 19(1):29-44.
164. van Haren N.E., Rijsdijk F., Schnack H.G., Picchioni M.M., Toulopoulou T., Weisbrod M., Sauer H., van Erp T.G., Cannon T.D., Huttunen M.O., Boomsma D.I., Hulshoff Pol H.E., Murray R.M., Kahn R.S. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biol. Psychiatry 2012, 71(10):915-921.
165. van Haren N.E., Schnack H.G., Koevoets M.G., Cahn W., Hulshoff Pol H.E., Kahn R.S. Trajectories of subcortical volume change in schizophrenia: a 5-year follow-up. Schizophr. Res. 2015, 10.1016/j.schres.2015.09.027.
166. Venkatasubramanian G., Jayakumar P.N., Gangadhar B.N., Keshavan M.S. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Res. 2008, 164(3):215-222.
167. Walther S. Psychomotor symptoms of schizophrenia map on the cerebral motor circuit. Psychiatry Res. 2015, 233(3):293-298.
168. Walther S., Stegmayer K., Horn H., Rampa L., Razavi N., Muller T.J., Strik W. The longitudinal course of gross motor activity in schizophrenia - within and between episodes. Front. Psychiatry 2015, 6:10.
169. Walther S., Stegmayer K., Horn H., Razavi N., Muller T.J., Strik W. Physical activity in schizophrenia is higher in the first episode than in subsequent ones. Front. Psychiatry 2014, 5:191.
170. Walther S., Strik W. Motor symptoms and schizophrenia. Neuropsychobiology 2012, 66(2):77-92.
171. Wardlaw J.M., Brindle W., Casado A.M., Shuler K., Henderson M., Thomas B., Macfarlane J., Munoz Maniega S., Lymer K., Morris Z., Pernet C., Nailon W., Ahearn T., Mumuni A.N., Mugruza C., McLean J., Chakirova G., Tao Y.T., Simpson J., Stanfield A.C., Johnston H., Parikh J., Royle N.A., De Wilde J., Bastin M.E., Weir N., Farrall A., Valdes Hernandez M.C., Group, S.C. A systematic review of the utility of 1.5 versus 3Tesla magnetic resonance brain imaging in clinical practice and research. Eur. Radiol. 2012, 22(11):2295-2303.
172. Whitty P.F., Owoeye O., Waddington J.L. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr. Bull. 2009, 35(2):415-424.
173. Wijemanne S., Jankovic J. Movement disorders in catatonia. J. Neurol. Neurosurg. Psychiatry 2014.
174. Wilcox J.A. Cerebellar atrophy and catatonia. Biol. Psychiatry 1991, 29(7):733-734.
175. Wilcox J.A. Structural brain abnormalities in catatonia. Neuropsychobiology 1993, 27(2):61-64.
176. Wilcox J.A., Nasrallah H.A. Organic factors in catatonia. Br. J. Psychiatry 1986, 149:782-784.
177. Woods B.T., Kinney D.K., Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch. Gen. Psychiatry 1986, 43(7):657-663.
178. Yoshida K., Bies R.R., Suzuki T., Remington G., Pollock B.G., Mizuno Y., Mimura M., Uchida H. Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Schizophr. Res. 2014, 153(1-3):184-188.
179. Yu C., Zhou Y., Liu Y., Jiang T., Dong H., Zhang Y., Walter M. Functional segregation of the human cingulate cortex is confirmed by functional connectivity based neuroanatomical parcellation. Neuroimage 2011, 54(4):2571-2581.
180. Zhao Q., Li Z., Huang J., Yan C., Dazzan P., Pantelis C., Cheung E.F., Lui S.S., Chan R.C. Neurological soft signs are not "soft" in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr. Bull. 2013.
181. Zhao Q., Ma Y.T., Lui S.S., Liu W.H., Xu T., Yu X., Tan S.P., Wang Z.R., Qu M., Wang Y., Huang J., Cheung E.F., Dazzan P., Chan R.C. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 43:72-78.